BMS-986122

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	AP313669884
CAS	313669-88-4
Structure
Molecular Weight	448.78

Description	≥98% (HPLC)
Solubility	DMSO: 20 mg/mL, clear
Assay	≥98% (HPLC)
Color	white to beige
Form	powder
Size	5MG, 25MG
Storage Conditions	2-8°C

Disruption of the Na+ Ion Binding Site as a Mechanism for Positive Allosteric Modulation of the Mu-Opioid Receptor

Kathryn E Livingston, John R Traynor

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18369-74.

PMID: 25489080

Ligand-Based Discovery of a New Scaffold for Allosteric Modulation of the μ-Opioid Receptor

Paola Bisignano, Neil T Burford, Yi Shang, Brennica Marlow, Kathryn E Livingston, Abigail M Fenton, Kristin Rockwell, Lauren Budenholzer, John R Traynor, Samuel W Gerritz, Andrew Alt, Marta Filizola

J Chem Inf Model. 2015 Sep 28;55(9):1836-43.

PMID: 26347990

Novel Opioid Receptor Agonists With Reduced Morphine-like Side Effects

Lianghan Zhu, Zhiying Cui, Qihua Zhu, Xiaoming Zha, Yungen Xu

Mini Rev Med Chem. 2018;18(19):1603-1610.

PMID: 30009707

Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors

Kathryn E Livingston, M Alexander Stanczyk, Neil T Burford, Andrew Alt, Meritxell Canals, John R Traynor

Mol Pharmacol. 2018 Feb;93(2):157-167.

PMID: 29233847

* Products or Services Interested: BMS-986122 (313669-88-4)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry